Moderna Inc (MIL:1MRNA)
€ 38.165 -0.445 (-1.15%) Market Cap: 14.61 Bil Enterprise Value: 9.32 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 44/100

Moderna Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 10:15PM GMT
Jessica Macomber Fye
JPMorgan Chase & Co, Research Division - Analyst

Hey, good afternoon, everyone. My name is Jess Fye. I'm the large cap biotech analyst at JPMorgan, and we're delighted to be continuing the conference today with Moderna.

Good news this year. We don't know how to switch rooms for Q&A. So Stéphane is going to give the presentation, and then we're going to go straight into Q&A after that. A couple of ways you can ask a question. There's mic runners in the room. So if you want to raise your hand, we'll try to get a mic to you or alternatively, you can submit a question electronically and I'll read it off the iPad up here.

So with that, let me pass it over to Moderna's CEO, Stéphane Bancel.

Stephane Bancel
Moderna, Inc. - CEO & Director

Thank you, Jess. Good afternoon, everybody, and thank you so much for joining us today. It's quite an impressive room for this presentation.

Before I start, let me remind you that we'll be making forward-looking statements, that investing in Moderna entails some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot